MicroRNA dysregulation in rhabdomyosarcoma: A new player enters the game

Cell Proliferation

Volumn 48, Issue 5, 2015, Pages 511-516

  Li, Zheng ^a   Yu, Xin ^a   Shen, Jianxiong ^a   Liu, Yang ^a   Chan, Matthew T V ^b   Wu, William K K ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; HUMAN; REGULATORY MECHANISM; RHABDOMYOSARCOMA; RNA ANALYSIS; ANIMAL; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY; SOFT TISSUE TUMOR; UPREGULATION;

ANIMALS; DOWN-REGULATION; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS; UP-REGULATION;

EID: 84940581981     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12199     Document Type: Article

References (52)

1. Keller C, Guttridge DC (2013) Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 280, 4323-4334.
2. Williamson D, Selfe J, Gordon T, Lu YJ, Pritchard-Jones K, Murai K et al. (2007) Role for amplification and expression of glypican-5 in rhabdomyosarcoma. Cancer Res. 67, 57-65.
3. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J et al. (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14, 369-381.
4. Ianzano ML, Croci S, Nicoletti G, Palladini A, Landuzzi L, Grosso V et al. (2014) Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. Oncotarget 5, 108-119.
5. Srivastava RK, Kaylani SZ, Edrees N, Li C, Talwelkar SS, Xu J et al. (2014) GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis. Oncotarget 5, 12151-12165.
6. Jothi M, Mal AK (2012) Too much AKT turns PAX3-FKHR dead: a prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma. Oncotarget 3, 1064-1065.
7. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R et al. (2009) Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 8, 172-175.
8. Ciesla M, Dulak J, Jozkowicz A (2014) MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development. Int. J. Biochem. Cell Biol. 53, 482-492.
9. Martinelli S, McDowell HP, Vigne SD, Kokai G, Uccini S, Tartaglia M et al. (2009) RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosom. Cancer 48, 975-982.
10. Avirneni-Vadlamudi U, Galindo KA, Endicott TR, Paulson V, Cameron S, Galindo RL. (2012) Drosophila and mammalian models uncover a role for the myoblast fusion gene TANC1 in rhabdomyosarcoma. J. Clin. Invest. 122, 403-407.
11. Crose LE, Galindo KA, Kephart JG, Chen C, Fitamant J, Bardeesy N et al. (2014) Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression. J. Clin. Invest. 124, 285-296.
12. Bian L, Wang Y, Liu Q, Xia J, Long JE (2015) Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes. Arch. Virol. 160, 173-182.
13. Armeanu-Ebinger S, Herrmann D, Bonin M, Leuschner I, Warmann SW, Fuchs J et al. (2012) Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. Exp. Cell Res. 318, 2567-2577.
14. Seitz G, Warmann SW, Fuchs J, Heitmann H, Mahrt J, Busse AC et al. (2008) Imaging of cell trafficking and metastases of paediatric rhabdomyosarcoma. Cell Prolif. 41, 365-374.
15. He F, Yao H, Wang J, Xiao Z, Xin L, Liu Z et al. (2015) Coxsackievirus B3 engineered to contain MicroRNA targets for muscle-specific MicroRNAs displays attenuated cardiotropic virulence in mice. J. Virol. 89, 908-916.
16. Fei B, Wu H (2013) MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol. Res. 20, 557-564.
17. Wu W, He X, Kong J, Ye B (2012) Mir-373 affects human lung cancer cells' growth and its E-cadherin expression. Oncol. Res. 20, 163-170.
18. Liang J, Zhang Y, Jiang G, Liu Z, Xiang W, Chen X et al. (2013) MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncol. Res. 21, 83-91.
19. Xiong X, Ren HZ, Li MH, Mei JH, Wen JF, Zheng CL et al. (2011) Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. Pathol. Oncol. Res. 17, 931-937.
20. Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV et al. (2014) MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget 5, 9106-9117.
21. Yang WB, Chen PH, Hsu Ts FuTF, Su WC, Liaw H et al. (2014) Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget 5, 740-753.
22. Wang K, Jia Z, Zou J, Zhang A, Wang G, Hao J et al. (2013) Analysis of hsa-miR-30a-5p expression in human gliomas. Pathol. Oncol. Res. 19, 405-411.
23. Chiang Y, Zhou X, Wang Z, Song Y, Liu Z, Zhao F et al. (2012) Expression levels of microRNA-192 and -215 in gastric carcinoma. Pathol. Oncol. Res. 18, 585-591.
24. Fei B, Wu H (2012) MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol. Res. 20, 557-564.
25. Li H, Yang BB (2012) Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 3, 1653-1668.
26. He X, Li J, Guo W, Liu W, Yu J, Song W et al. (2014) Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma. Oncotarget 5, 6654-6669.
27. Chakravarthi BV, Pathi SS, Goswami MT, Cieslik M, Zheng H, Nallasivam S et al. (2014) The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. Oncotarget 5, 6654-6669.
28. Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T et al. (2014) MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget 5, 7013-7726.
29. Ouchida M, Kanzaki H, Ito S, Hanafusa H, Jitsumori Y, Tamaru S et al. (2012) Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS ONE 7, e44095.
30. Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y et al. (2015) DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer 18, 43-54.
31. Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X et al. (2013) MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PLoS ONE 8, e83080.
32. Li Z, Yu X, Shen J, Wu WK, Chan MT (2015) MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell Prolif. 48, 1-6.
33. Yu X, Li Z (2014) MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review). Int. J. Mol. Med. 34, 923-933.
34. Wei JS, Johansson P, Chen QR, Song YK, Durinck S, Wen X et al. (2009) microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin. Cancer Res. 15, 5560-5568.
35. Gougelet A, Perez J, Pissaloux D, Besse A, Duc A, Decouvelaere AV et al. (2011) miRNA profiling: how to bypass the current difficulties in the diagnosis and treatment of Sarcomas. Sarcoma 2011, 460650.
36. Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A et al. (2014) Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 14, 880.
37. Sarver AL, Li L, Subramanian S (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70, 9570-9580.
38. Reichek JL, Duan F, Smith LM, Gustafson DM, O'Connor RS, Zhang C et al. (2011) Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Clin. Cancer Res. 17, 1463-1473.
39. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M et al. (2009) The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J. Clin. Invest. 119, 2366-2378.
40. Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J et al. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J. Biol. Chem. 284, 29596-29604.
41. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K et al. (2010) MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br. J. Cancer 102, 1769-1777.
42. Rao PK, Missiaglia E, Shields L, Hyde G, Yuan B, Shepherd CJ et al. (2010) Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells. FASEB J. 24, 3427-3437.
43. Diao Y, Guo X, Jiang L, Wang G, Zhang C, Wan J et al. (2014) miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. J. Biol. Chem. 289, 529-539.
44. Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A et al. (2012) Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid. Redox Signal. 16, 113-127.
45. Sun MM, Li JF, Guo LL, Xiao HT, Dong L, Wang F et al. (2014) TGF-beta1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma. Oncogene 33, 2075-2086.
46. Doros L, Yang J, Dehner L, Rossi CT, Skiver K, Jarzembowski JA et al. (2012) DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr. Blood Cancer 59, 558-560.
47. Huang HJ, Liu J, Hua H, Li SE, Zhao J, Yue S et al. (2014) MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis. Oncotarget 5, 2161-2175.
48. Taulli R, Foglizzo V, Morena D, Coda DM, Ala U, Bersani F et al. (2014) Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. Oncogene 33, 2354-2362.
49. Li L, Sarver AL, Alamgir S, Subramanian S (2012) Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab. Invest. 92, 571-583.
50. Chen CF, He X, Arslan AD, Mo YY, Reinhold WC, Pommier Y et al. (2011) Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness. Mol. Pharmacol. 79, 735-741.
51. Miyachi M, Tsuchiya K, Yoshida H, Yagyu S, Kikuchi K, Misawa A et al. (2010) Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 400, 89-93.
52. Dela Cruz F, Matushansky I (2011) MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas. Discov. Med. 12, 307-317.